Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

China flag China · Delayed Price · Currency is CNY
8.11
+0.05 (0.62%)
Jul 29, 2025, 3:04 PM CST
0.62%
Market Cap5.36B
Revenue (ttm)1.71B
Net Income (ttm)-910.63M
Shares Out661.28M
EPS (ttm)-1.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,764,312
Average Volume14,321,497
Open8.13
Previous Close8.06
Day's Range7.98 - 8.20
52-Week Range3.23 - 16.49
Beta0.46
RSI45.85
Earnings DateAug 28, 2025

About Xiangxue Pharmaceutical

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 2,769
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300147
Full Company Profile

Financial Performance

In 2024, Xiangxue Pharmaceutical's revenue was 1.86 billion, a decrease of -19.16% compared to the previous year's 2.30 billion. Losses were -858.56 million, 120.7% more than in 2023.

Financial Statements

News

There is no news available yet.